CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 FibroGen, Inc - FGEN CFD

    19.35
    8.49%
    0.10
    最低: 17.62
    最高: 19.41
    Market Trading Hours* (UTC) Open now
    Closes on Monday at 20:00

    Mon - Fri: 13:30 - 20:00

    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 0.10
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    FibroGen Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    关键数据
    前收盘价* 17.79
    开仓* 17.62
    1 年变化* 77.09%
    日范围* 17.62 - 19.41
    52 周范围 8.67-25.69
    平均交易量（10 天） 936.69K
    平均交易量（3 个月) 18.62M
    市值 1.74B
    市盈率 -100.00K
    流通股 97.58M
    收入 116.07M
    EPS -3.27
    股息（收益率 %） N/A
    贝塔 0.79
    下一个财报发布日期 Aug 7, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low
    Jun 2, 2023 17.79 -0.94 -5.02% 18.73 19.05 17.34
    Jun 1, 2023 17.18 0.22 1.30% 16.96 17.59 16.70
    May 31, 2023 17.16 0.15 0.88% 17.01 17.61 16.72
    May 30, 2023 17.04 0.47 2.84% 16.57 17.33 16.46
    May 26, 2023 16.65 0.03 0.18% 16.62 16.80 16.33
    May 25, 2023 16.82 0.16 0.96% 16.66 16.91 16.44
    May 24, 2023 16.90 -0.05 -0.29% 16.95 17.33 16.51
    May 23, 2023 17.27 0.06 0.35% 17.21 18.03 16.99
    May 22, 2023 17.16 -0.14 -0.81% 17.30 18.02 16.96
    May 19, 2023 17.49 -0.07 -0.40% 17.56 18.07 17.20
    May 18, 2023 17.53 0.01 0.06% 17.52 17.89 17.29
    May 17, 2023 17.77 0.80 4.71% 16.97 17.86 16.92
    May 16, 2023 17.40 0.25 1.46% 17.15 17.51 17.08
    May 15, 2023 17.58 0.46 2.69% 17.12 17.91 17.03
    May 12, 2023 17.31 -0.11 -0.63% 17.42 17.66 17.09
    May 11, 2023 17.48 -0.12 -0.68% 17.60 18.00 17.38
    May 10, 2023 17.65 0.25 1.44% 17.40 17.84 17.17
    May 9, 2023 17.30 1.25 7.79% 16.05 17.89 15.97
    May 8, 2023 17.61 0.58 3.41% 17.03 17.73 16.55
    May 5, 2023 17.29 1.14 7.06% 16.15 17.55 15.83

    FibroGen, Inc Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Wednesday, June 7, 2023

    时间（协调世界时） (UTC)

    15:00

    国家/地区

    US

    事件

    FibroGen Inc Annual Shareholders Meeting
    FibroGen Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Friday, June 16, 2023

    时间（协调世界时） (UTC)

    15:00

    国家/地区

    US

    事件

    FibroGen Inc Annual Shareholders Meeting
    FibroGen Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Monday, August 7, 2023

    时间（协调世界时） (UTC)

    10:59

    国家/地区

    US

    事件

    Q2 2023 FibroGen Inc Earnings Release
    Q2 2023 FibroGen Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 6, 2023

    时间（协调世界时） (UTC)

    10:59

    国家/地区

    US

    事件

    Q3 2023 FibroGen Inc Earnings Release
    Q3 2023 FibroGen Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 140.734 235.309 176.319 256.577 212.958
    收入 140.734 235.309 176.319 256.577 212.958
    总营业费用 441.759 523.839 368.199 345.891 299.651
    销售/一般/行政费用，总计 127.474 120.557 97.238 126.557 63.812
    研究与开发 296.791 387.043 252.924 209.265 235.839
    营业收入 -301.025 -288.53 -191.88 -89.314 -86.693
    利息收入（费用），非经营净值 6.156 -2.153 3.151 12.672 0.577
    税前净收入 -294.869 -290.683 -188.729 -76.642 -86.116
    税后净收入 -295.227 -291.03 -189.089 -76.97 -86.42
    未计算非常项目前的净收益 -293.654 -290.023 -189.291 -76.97 -86.42
    净收入 -293.654 -290.023 -189.291 -76.97 -86.42
    普通股股东可获收益 (不含非经常性项目) -293.654 -290.023 -189.291 -76.97 -86.42
    普通股股东可获收益 (含非經常性項目) -293.654 -290.023 -189.291 -76.97 -86.42
    摊薄净收入 -293.654 -290.023 -189.291 -76.97 -86.42
    摊薄后加权平均股 93.582 92.349 89.854 86.633 84.062
    扣除特别项目的每股摊薄盈利 -3.13793 -3.14051 -2.10665 -0.88846 -1.02805
    每股正常摊薄盈利 -3.13793 -3.14051 -2.10665 -0.88846 -1.02805
    非常规项目总计
    收入成本，共计 20.28 12.871 8.869 1.147
    毛利 120.454 222.438 167.45 255.43
    Depreciation / Amortization 0.587 4.639 10.369 10.307
    Other Operating Expenses, Total -3.373 -1.271 -1.201 -1.385
    Equity In Affiliates 1.573 1.007 -0.202
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 36.161 34.367 15.735 29.806 60.827
    收入 36.161 34.367 15.735 29.806 60.827
    收入成本，共计 3.491 4.925 4.308 6.809 4.238
    毛利 32.67 29.442 11.427 22.997 56.589
    总营业费用 112.252 100.519 109.392 108.03 123.82
    销售/一般/行政费用，总计 34.275 33.966 29.902 30.258 30.564
    研究与开发 74.486 61.628 75.182 70.963 89.018
    Other Operating Expenses, Total
    营业收入 -76.091 -66.152 -93.657 -78.224 -62.993
    利息收入（费用），非经营净值 -1.336 -0.195 1.714 5.058 -0.419
    税前净收入 -77.427 -66.347 -91.943 -73.166 -63.412
    税后净收入 -77.501 -66.455 -92.057 -73.189 -63.525
    Equity In Affiliates 0.796 0.28 0.407 0.565 0.32
    未计算非常项目前的净收益 -76.705 -66.175 -91.65 -72.624 -63.205
    净收入 -76.705 -66.175 -91.65 -72.624 -63.205
    普通股股东可获收益 (不含非经常性项目) -76.705 -66.175 -91.65 -72.624 -63.205
    普通股股东可获收益 (含非經常性項目) -76.705 -66.175 -91.65 -72.624 -63.205
    摊薄净收入 -76.705 -66.175 -91.65 -72.624 -63.205
    摊薄后加权平均股 94.691 94.035 93.767 93.475 93.043
    扣除特别项目的每股摊薄盈利 -0.81006 -0.70373 -0.97742 -0.77694 -0.67931
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常摊薄盈利 -0.81006 -0.70373 -0.97742 -0.77694 -0.67931
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 492.826 474.059 755.11 702.49 690.015
    现金和短期投资 422.008 405.19 686.537 533.757 621.402
    Cash 135.819 111.422 88.046 40.715 38.783
    现金等价物 19.881 59.801 590.347 85.551 50.475
    短期投资 266.308 233.967 8.144 407.491 532.144
    应收账款总额，净额 16.299 25.401 41.883 153.665 63.684
    Accounts Receivable - Trade, Net 28.387 36.331 46.01 158.51 16.474
    Prepaid Expenses 9.73 7.383 8.353 6.464 4.929
    Total Assets 610.087 773.821 826.84 857.397 880.598
    Property/Plant/Equipment, Total - Net 100.933 120.15 65.296 84.276 127.198
    Property/Plant/Equipment, Total - Gross 253.644 252.362 199.305 195.752 192.397
    Accumulated Depreciation, Total -152.711 -132.212 -134.009 -111.476 -65.199
    Long Term Investments 9.409 171.621 2.972 61.118 55.82
    Other Long Term Assets, Total 6.919 7.991 3.462 9.513 7.565
    Total Current Liabilities 273.562 225.497 163.187 102.745 89.033
    Accounts Payable 30.758 26.097 24.789 6.088 9.139
    Accrued Expenses 229.639 180.356 104.384 83.816 66.123
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 13.129 19.033 21.684 0.49 13.771
    Total Liabilities 631.534 564.675 404.662 341.262 371.399
    Total Long Term Debt 17.054 17.616 44.088 55.531 113.955
    Long Term Debt 16.917 17.613 18.697 16.78 16.798
    Capital Lease Obligations 0.137 0.003 25.391 38.751 97.157
    Minority Interest 19.967 19.967 19.271 19.271 19.271
    Other Liabilities, Total 320.951 292.403 169.441 163.715 149.14
    Total Equity -21.447 209.146 422.178 516.135 509.199
    Redeemable Preferred Stock 0 0 0 0 0
    Common Stock 0.942 0.929 0.914 0.877 0.854
    Additional Paid-In Capital 1541.02 1476.41 1399.77 1300.72 1226.45
    Retained Earnings (Accumulated Deficit) -1557.69 -1264.03 -974.011 -784.72 -715.827
    Other Equity, Total -5.72 -4.163 -4.499 -0.747 -2.281
    Total Liabilities & Shareholders’ Equity 610.087 773.821 826.84 857.397 880.598
    Total Common Shares Outstanding 94.1661 92.881 91.441 87.657 85.432
    Total Inventory 40.436 31.015 16.53 6.887
    Other Current Assets, Total 4.353 5.07 1.807 1.717
    Current Port. of LT Debt/Capital Leases 0.036 0.011 12.33 12.351
    Deferred Income Tax 9.192 8.675
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 430.549 492.826 474.224 520.643 524.415
    现金和短期投资 355.949 422.008 408.52 438.133 428.075
    Cash 145.81 135.819 104.509 128.152 165.436
    现金等价物 42.74 19.881 51.451 39.606 20.46
    短期投资 167.399 266.308 252.56 270.375 242.179
    应收账款总额，净额 17.654 16.299 15.328 33.573 43.883
    Accounts Receivable - Trade, Net 29.217 28.387 29.665 60.352 82.638
    Total Inventory 42.456 40.436 39.95 40.899 43.067
    Prepaid Expenses 14.49 9.73 10.426 8.038 9.39
    Other Current Assets, Total 4.353
    Total Assets 538.544 610.087 608.837 686.789 745.934
    Property/Plant/Equipment, Total - Net 95.367 100.933 105.19 109.159 114.871
    Property/Plant/Equipment, Total - Gross 253.644
    Accumulated Depreciation, Total -152.711
    Long Term Investments 5.884 9.409 22.411 50.414 97.643
    Other Long Term Assets, Total 6.744 6.919 7.012 6.573 9.005
    Total Current Liabilities 254.746 273.562 251.994 240.34 255.374
    Accounts Payable 71.282 30.758 19.323 29.36 36.353
    Accrued Expenses 166.969 229.639 224.577 202.681 211.518
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0.036
    Other Current Liabilities, Total 16.495 13.129 8.094 8.299 7.503
    Total Liabilities 587.396 631.534 582.531 583.009 587.886
    Total Long Term Debt 17.276 17.054 15.422 16.439 17.374
    Long Term Debt 17.276 16.917 15.422 16.439 17.374
    Capital Lease Obligations 0.137
    Deferred Income Tax
    Minority Interest 19.967 19.967 19.967 19.967 19.967
    Other Liabilities, Total 295.407 320.951 295.148 306.263 295.171
    Total Equity -48.852 -21.447 26.306 103.78 158.048
    Redeemable Preferred Stock 0 0 0 0
    Common Stock 0.966 0.942 0.939 0.937 0.933
    Additional Paid-In Capital 1589.15 1541.02 1524.23 1509.64 1490.86
    Retained Earnings (Accumulated Deficit) -1634.39 -1557.69 -1491.51 -1399.86 -1327.24
    Other Equity, Total -4.57 -5.72 -7.346 -6.93 -6.505
    Total Liabilities & Shareholders’ Equity 538.544 610.087 608.837 686.789 745.934
    Total Common Shares Outstanding 96.623 94.1661 93.936 93.733 93.289
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 -293.654 -290.023 -189.291 -76.97 -86.42
    经营活动产生的现金 -145.933 -82.232 81.602 -78.705 -76.144
    经营活动产生的现金 10.604 14.809 22.047 21.454 6.562
    非现金物品 66.687 132.899 74.216 62.47 52.112
    已付现金利息 0.104 0.094 0.135 0.174 0.218
    营运资金的变化 70.43 60.083 174.63 -85.659 -48.398
    投资活动产生的现金 89.116 -426.972 452.487 120.018 -522.123
    资本支出 -38.741 -30.186 -3.994 -5.762 -8.02
    其他投资现金流量项目，总计 127.857 -396.786 456.481 125.78 -514.103
    融资活动产生的现金 46.776 -0.563 13.343 -4.3 13.875
    融资现金流项目 -6.62 -7.372 -11.463 -12.75 -15.612
    股票的发行（报废），净额 53.934 12.701 37.829 20.778 29.847
    债务的发行（退还），净额 -0.538 -5.892 -13.023 -12.328 -0.36
    外汇效应 -5.482 2.597 4.695 -0.005 -0.008
    现金净变化 -15.523 -507.17 552.127 37.008 -584.4
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -76.705 -293.654 -227.479 -135.829 -63.205
    Cash From Operating Activities -101.591 -145.933 -93.42 -41.54 -8.476
    Cash From Operating Activities 2.965 10.604 7.914 5.235 2.584
    Non-Cash Items 18.148 66.687 49.928 34.441 17.77
    Changes in Working Capital -45.999 70.43 76.217 54.613 34.375
    Cash From Investing Activities 103.482 89.116 88.023 43.24 25.935
    Capital Expenditures -0.591 -38.741 -38.408 -37.543 -36.638
    Other Investing Cash Flow Items, Total 104.073 127.857 126.431 80.783 62.573
    Cash From Financing Activities 31.485 46.776 -1.898 -0.806 -2.893
    Financing Cash Flow Items 0 -6.62 -4.562 -3.361 -2.974
    Issuance (Retirement) of Stock, Net 31.657 53.934 2.989 2.779 0.183
    Issuance (Retirement) of Debt, Net -0.172 -0.538 -0.325 -0.224 -0.102
    Foreign Exchange Effects -0.526 -5.482 -7.968 -4.359 0.107
    Net Change in Cash 32.85 -15.523 -15.263 -3.465 14.673
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    PRIMECAP Management Company Investment Advisor 14.4767 14126697 231619 2023-03-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.0286 8810326 -613439 2023-03-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 6.2737 6122003 89685 2023-03-31 LOW
    Astellas Pharma Inc Corporation 5.0915 4968367 0 2023-01-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.1772 4076167 -188810 2023-03-31 LOW
    Point72 Asset Management, L.P. Hedge Fund 3.5113 3426427 -1355218 2023-03-31 HIGH
    First Trust Advisors L.P. Investment Advisor 2.7884 2720975 -254678 2023-03-31 LOW
    Baker Bros. Advisors LP Hedge Fund 2.7027 2637384 1262173 2023-03-31 LOW
    Armistice Capital LLC Hedge Fund 2.3693 2312000 -1552000 2023-03-31 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.7703 1727545 70450 2023-03-31 LOW
    Two Sigma Investments, LP Hedge Fund 1.7676 1724909 512435 2023-03-31 HIGH
    Schroder Investment Management North America Inc. Investment Advisor 1.5138 1477161 -246616 2023-03-31 LOW
    Artisan Partners Limited Partnership Investment Advisor 1.3847 1351230 1351230 2023-03-31 LOW
    Assenagon Asset Management S.A. Investment Advisor 1.3779 1344583 1344583 2023-03-31 HIGH
    Jacobs Levy Equity Management, Inc. Investment Advisor/Hedge Fund 1.1877 1159027 -348288 2023-03-31 MED
    Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 1.1157 1088768 593915 2023-03-31 LOW
    Eventide Asset Management, LLC Investment Advisor 0.9838 960000 960000 2023-03-31 MED
    Nuveen LLC Pension Fund 0.9185 896293 328958 2023-03-31 LOW
    Adage Capital Management, L.P. Hedge Fund 0.8711 850000 -1800000 2023-03-31 LOW
    Eagle Asset Management, Inc. Investment Advisor/Hedge Fund 0.8488 828307 -74825 2023-03-31 LOW

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    535K+

    交易者

    87K+

    每月活跃客户

    $113M+

    每月投资额

    $64M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    FibroGen, Inc Company profile

    关于 FibroGen Inc

    FibroGen, Inc.是一家生物制药公司。 该公司从事发现、开发和商业化一流的治疗方法。 公司运用其在低氧诱导因子（HIF）生物学、2-氧代谷氨酸酶学和结缔组织生长因子（CTGF）生物学方面的能力，推进治疗贫血、纤维化疾病和癌症的药物。 公司的产品Roxadustat是一种口服的小分子HIF-脯氨酸羟化酶（HIF-PH）活性抑制剂，用于治疗慢性肾脏病（CKD）引起的贫血。 该公司还在开发Roxadustat，用于治疗与骨髓增生异常综合征（MDS）相关的贫血症。 公司还在开发Roxadustat，用于治疗化疗引起的贫血（CIA）。 Pamrevlumab，一种抗CTGF的人类单克隆抗体，用于治疗特发性肺纤维化（IPF）、局部晚期不可切除的胰腺癌（LAPC）和杜兴氏肌肉萎缩症（DMD）。

    Industry: Biotechnology & Medical Research (NEC)

    409 Illinois Street
    SAN FRANCISCO
    CALIFORNIA 94158
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    Oil - Crude

    72.05 Price
    +0.130% 1D Chg, %
    多头隔夜费 -0.0149%
    空头隔夜费 -0.0070%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    BTC/USD

    25,637.95 Price
    -5.950% 1D Chg, %
    多头隔夜费 -0.0616%
    空头隔夜费 0.0137%
    隔夜费时间 21:00 (UTC)
    价差 60.00

    Gold

    1,962.33 Price
    +0.690% 1D Chg, %
    多头隔夜费 -0.0185%
    空头隔夜费 0.0103%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    US100

    14,525.30 Price
    -0.150% 1D Chg, %
    多头隔夜费 -0.0255%
    空头隔夜费 0.0032%
    隔夜费时间 21:00 (UTC)
    价差 1.8

    还在找一位您可以信任的经纪商吗？

    加入成为全球535,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易